Insiders who reported open-market trades in the last 12 months at the companies Gregory D. Davis files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Gregory D. Davis is a corporate insider, tracked as Head of Research & Technology of SANGAMO THERAPEUTICS, INC (SGMO). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Gregory D. Davis last file a Form 4?
The most recent primary Form 4 on record is dated 27 May 2026, one of 12 filings going back to 2024.
Has Gregory D. Davis been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($18K) across all tracked filings.
Gregory D. Davis is Head of Research & Technology of SANGAMO THERAPEUTICS, INC (SGMO). 12 SEC Form 4 filings on record going back to 2024, most recently on 27 May 2026. Most recent open-market trade: sold $18K of SGMO on 23 April 2026. Lifetime open-market sales: $18K.
Recent transactions
13
The latest 13 SEC Form 4 transactions reported by Gregory D. Davis.
InsiderAlpha's records for Gregory D. Davis go back to 2024: 12 primary Form 4 filings, an average of 4.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
